Document:

Exhibit
10.4

 

AMENDMENT
TO ADVISORY BOARD AGREEMENT

 

This
Amendment to Advisory Board Agreement (this “Amendment”) is executed this [_] day of January, 2022 (the “Effective
Date”), by and between BIOLIFE4D, a Delaware limited liability company formerly known as BIOGEN3D Corporation (the “Company”)
and Ibrahim Tarik Ozbolat (“Advisor”).

 

WHEREAS,
the Company and Advisor are parties to that certain Advisory Board Agreement, dated May 31, 2017 (the “Agreement”)
(all capitalized terms used herein but not otherwise defined shall have the meaning ascribed to such terms in the Agreement); and

 

WHEREAS,
the Company and Advisor desire to amend certain provisions of the Agreement as set forth in this Amendment.

 

NOW,
THEREFORE, in consideration of the provisions and undertakings set forth herein, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and Advisor, intending to be legally bound, hereby agree as follows:

 

	1.	Amendment
    to Agreement. The Agreement is hereby amended as follows: Exhibit A to the Agreement is hereby deleted in its entirety
    and replaced with the Exhibit A attached hereto.
	 	 
	2.	Acknowledgments.
    The Company and Advisor hereby acknowledge and agree as follows:

 

	 	a.	The
    Company has paid all compensation due to Advisor pursuant to the Agreement for any and all services provided by Advisor to the Company
    prior to January 1, 2022; and
	 	b.	as
    of January 1, 2022, Advisor owns (i) 2,500 shares of non-voting common stock of the Company, and (ii) options to purchase 10,000
    shares of non-voting common stock of the Company.

 

	3.	Force
    and Effect of Agreement. Except as expressly modified hereby, the Agreement and all exhibits thereto are in all respects
    ratified and confirmed, and all of the terms, conditions and provisions thereof shall remain in full force and effect. This Amendment
    shall be effective upon execution and delivery by each of the parties as of the Effective Date. From and after the Effective Date,
    any reference to the Agreement, as the case may be, shall be deemed a reference to the Agreement as amended hereby. 
	 	 
	4.	Governing
    Law. This Amendment will be governed by Illinois law without regards to its conflict of laws provisions.
	 	 
	5.	Counterparts.
    This Amendment may be executed in one or more counterparts, including facsimile or electronic counterparts, each of which shall be
    deemed to be an original copy of this Amendment, and all of which, when taken together, shall be deemed to constitute one and the
    same agreement. Counterparts may be delivered via facsimile, electronic mail (including PDF, .tiff or any electronic
    signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any
    counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all
    purposes.

 

[Signature
page follows.]

 

    	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment by affixing their signatures where indicated below.

 

	COMPANY:	 	ADVISOR:
	 	 	 
	BIOLIFE4D
    CORPORATION 	 	 
	 	 	 	 
	By:	/s/
    Steven Morris	 	/s/
    Ibrahim Tarik Ozbolat
	Name:	Steven
                                            Morris
	 	Ibrahim
    Tarik Ozbolat
	Its:	Chief
    Executive Officer	 	

 

[Signature
Page to Amendment to Advisory Board Agreement]

 

    	 

     

    

 

Exhibit
A

 

“Services”:

 

Effective
as of January 1, 2022, “Services” shall be as follows:

 

	 	A.	Participate
    in a regularly scheduled weekly remote Zoom call for one hour per call.
	 	B.	Be
    reasonably accessible to the Company via phone and/or Zoom to provide guidance on overall strategy, laboratory setup and development,
    research strategy and techniques, research development and implementation, current lab operations and research, and other issues
    on an as-needed basis.
	 	C.	Help
    identify, advise on and recruit potential employees, consultants, directors, advisors and other service providers to the Company.
	 	D.	Be
    reasonably available to visit the Company’s labs in Houston, TX (“JLABS”) based on schedule availability.

 

“Compensation”:

 

Effective
as of January 1, 2022, “Compensation” shall be as follows:

 

The
Company shall pay Advisor: (a) $1,750 per month during the Term, (b) $400 for each hour Advisor spends at JLABS in person, and (c) 2,500
shares of BIOLIFE4D stock at the end of each 6 month period Advisor is engaged. All compensation shall be payable at the end of each
month during the Term.Exhibit
10.34

 

CFO
AGREEMENT

 

This
CFO AGREEMENT is dated as of February 1, 2022 (this “Agreement”), and is by and between BIOLIFE4D Corporation, a Delaware
corporation, (the “Company”), and Wesley Ramjeet (the “Consultant”).

 

WHEREAS,
the Board of Directors of the Company desires to engage Consultant to provide consulting services, upon the terms and subject to the
conditions hereinafter set forth; and

 

WHEREAS,
the Consultant has agreed to provide such consulting services, upon the terms and subject to the conditions hereinafter set forth.

 

NOW,
THEREFORE, in consideration of the above premises and for other good and valuable consideration, the receipt and sufficiency of which
hereby are acknowledged, the parties hereto agree as follows:

 

	1.	Consulting
                                            Services. The Company, through the action of its Board of Directors (the “Board”),
                                            hereby engages the Consultant, and the Consultant will serve the Company, as a consultant.
                                            During the term of this Agreement, the Consultant will serve as the non-employee chief financial
                                            officer (“CFO”) of the Company on a part-time basis. The Company confirms that
                                            the Consultant has been duly appointed as the CFO of the Company and will remain as an executive
                                            officer of the Company during the term of this Agreement.

 

	 	Duties	 	The
                                            Consultant will perform all duties typically required of a Chief Financial Officer, including,
                                            but not limited to accounting oversight for the preparation of the Company’s pending
                                            registration statement which includes responding to comments of the United States Securities
                                            and Exchange Commission (the “SEC”) and quarterly and annual financial statements
                                            to be filed with the SEC.

     

    The
    Consultant will report directly to the CEO.

     

    The
    Company will accept and maintain all responsibility for its day-to-day accounting and bookkeeping functions and the Company further
    warrants that it is in full compliance with all of its corporate income taxes and/or payroll tax requirements and/or filings and
    will continue to provide for and will timely make all future tax payments required by the Company.

    

 

	 	Term	 	This
    engagement shall commence upon execution of this Agreement and shall continue in full force and effect for a period of two years.
    The Agreement may be extended thereafter by mutual agreement unless terminated earlier by operation of and in accordance with this
    agreement. 

 

    	1

    	 

    

 

	 	Compensation	 	As
                                            compensation for the services rendered pursuant to this Agreement, Company shall pay Consultant
                                            $5,000 upon execution of this Agreement which shall constitute the first month’s compensation
                                            and then $5,000 per month for the next 23 months (unless this Agreement is terminated) for
                                            up to 20 hours of services per month. Any additional time over 20 hours per month shall be
                                            billed at $350 per hour.

     

    In
    addition, the Consultant shall be granted 2,000 shares of the Company’s common stock pursuant to the Company’s 2021 Restricted
    Stock Plan at the end of each month this Agreement is in force. All
    securities issued to the Consultant shall be subject to the same restrictions and lock-ups imposed on other officers of the Company.

 

	2.	Expenses.
                                            During the term of this Agreement, the Consultant shall bill, and the Company shall reimburse
                                            the Consultant for reasonable and pre-approved out-of-pocket expenses which are incurred
                                            in connection with the performance of the duties hereunder.
	 	 
	3.	Indemnification:
                                            The Company agrees to defend, indemnify (including, without limitation, by providing
                                            for the advancement of expenses and reasonable attorneys’ fees) and hold harmless the
                                            Consultant for any and all acts taken or omitted to be taken by the Consultant hereunder
                                            (except for bad faith, gross negligence or willful misconduct) as if the Consultant was an
                                            officer of the Company as provided in the charter and bylaws of the Company in accordance
                                            with the same terms, conditions, limitations, standards, duties, rights and obligations as
                                            an officer. The provisions of this Section shall survive any termination of this Agreement.
	 	 
	4.	Termination.
                                            Either party may terminate this Agreement at any time by 30 days written notice to the other
                                            party.
	 	 
	5.	Independent
                                            Contractor. This Agreement shall not render the Consultant an employee, partner,
                                            agent of, or joint venture with the Company for any purpose. The Consultant is and will remain
                                            an independent contractor in his relationship to the Company. The Company shall not be responsible
                                            for withholding taxes with respect to the Consultant’s compensation hereunder. The
                                            Consultant shall have no claim against the Company hereunder or otherwise for vacation pay,
                                            sick leave, retirement benefits, social security, worker’s compensation, health or
                                            disability benefits, unemployment insurance benefits, or employee benefits of any kind.
	 	 
	6.	Successors
                                            and Assigns. All of the provisions of this Agreement shall be binding upon and inure
                                            to the benefit of the parties hereto and their respective heirs, if any, successors, and
                                            assigns.
	 	 
	7.	Choice
                                            of Law. The laws of the state of Delaware shall govern the validity of this Agreement,
                                            the construction of its terms and the interpretation of the rights and duties of the parties
                                            hereto.
	 	 
	8.	Arbitration.
                                            Any controversies arising out of the terms of this Agreement, or its interpretation
                                            shall be heard in Cook County, Illinois, in accordance
                                            with the rules of the American Arbitration Association, and the judgment upon award may be
                                            entered in any court having jurisdiction thereof.
	 	 
	9.	Waiver.
                                            Waiver by one party hereto of breach of any provision of this Agreement by the other shall
                                            not operate or be construed as a continuing waiver.
	 	 
	10.	Assignment.
                                            The Consultant shall not assign any of his rights under this Agreement or delegate the performance
                                            of any of his duties hereunder, without the prior written consent of the Company.

 

    	2

    	 

    

 

	11.	Notices.
                                            Any notice, request, instruction, or other document required by the terms of this Agreement,
                                            or deemed by any of the Parties hereto to be desirable, to be given to any other Party hereto
                                            shall be in writing and shall be given by personal delivery, overnight delivery, mailed by
                                            registered or certified mail, postage prepaid, with return receipt requested, or sent by
                                            electronic mail (with receipt confirmed) to the addresses of the Parties as follows:

 

	 	If
    to the Consultant:	Wesley
                                            Ramjeet

    8108
    Woodslanding Trail

    West
    Palm Beach, FL 33411

    wesley@ppmtgroup.com

     

	 	If
    to the Company:	Steven
                                            Morris, CEO

    BIOLIFE4D
    Corporation

    250
    Parkway Drive

    Suite
    150

    Lincolnshire,
    IL 60069

    smorris@biolife4d.com

 

The
persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal
delivery or overnight delivery in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the
time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions
of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. If notice is given by electronic
mail transmission in accordance with the provisions of this Section, such notice shall be conclusively deemed given at the time of delivery
if between the hours of 9:00 a.m. and 5:00 p.m. Pacific time on a business day (“business hours”) and if not during business
hours, at 9:00 a.m. on the next business day following delivery, provided a delivery confirmation is obtained by the sender.

 

	12.	Modification
                                            or Amendment. No amendment, change or modification of this Agreement shall be valid
                                            unless in writing signed by the parties hereto
	 	 
	13.	Entire
                                            Understanding. This document and any exhibit attached constitute the entire understanding
                                            and agreement of the parties, and any and all prior agreements, understandings, and representations
                                            are hereby terminated and canceled in their entirety and are of no further force and effect.
	 	 
	14.	Unenforceability
                                            of Provisions. If any provision of this Agreement, or any portion thereof, is held
                                            to be invalid and unenforceable, then the remainder of this Agreement shall nevertheless
                                            remain in full force and effect.
	 	 
	15.	Attorneys’
                                            Fees. In the event any Party hereto shall commence legal proceedings against the
                                            other to enforce the terms hereof, or to declare rights hereunder, as the result of a breach
                                            of any covenant or condition of this Agreement, the prevailing party in any such proceeding
                                            shall be entitled to recover from the losing party its costs of suit, including reasonable
                                            attorneys’ fees, as may be fixed by the court or determined by an arbitrator.

 

(SIGNATURE
PAGE FOLLOWS)

 

    	3

    	 

    

 

IN
WITNESS WHEREOF the undersigned have executed this Agreement as of the day and year first written above. The parties hereto agree that
facsimile signatures shall be as effective as if originals.

 

	BIOLIFE4D
    Corporation 	 	Wesley
    Ramjeet 
	 	 	 
	 	/s/
    Steven Morris	 	 	/s/
    Wesley Ramjeet
	By:	Steven
                                            Morris

    
	 	By:	Wesley
                                            Ramjeet

    

	Its:	Chief
    Executive Officer	 	 	 

 

    	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]